This Slide contains information about Cause, Symptoms, Prevalence, Pathophysiology, Diagnosis, Complications and Management of Diabetes mellitus. It includes both Conventional and Naturopathic management.
The worldwide explosion of obesity has resulted in an ever-increasing prevalence of type 2 diabetes. The importance of insulin resistance and β-cell dysfunction to the pathogenesis of type 2 diabetes was debated for a long time; many thought that insulin resistance was the main abnormality in type 2 diabetes, and that inability to secrete insulin was a late manifestation. This notion is now challenged. This presentation deals with the important contributing factors in the development of type 2 diabetes mellitus.
Shashikiran Umakanth made this presentation at the "First Endocrine Update Program” – ENDO EGYPT 2015, from 17-20 December 2015 in the Historic City of Luxor, Egypt. This endocrine update was organised by the Egyptian Association of Endocrinology , Diabetes and Atherosclerosis (EAEDA) in collaboration with the Endocrine Society, USA.
Type 2 dm gdm new updates & guidelinesSachin Verma
Type 2 diabetes is a multifactorial disorder characterised by progressive pancreatic beta-cell dysfunction and insulin- resistance, leading to relative insulin deficiency, chronic hyperglycaemia, and various complications.
The treatment options for this disorder, which aim at correcting one or other of the two major pathophysiological mechanisms, have been hamstrung by unacceptable side-effects, lack of patient acceptability, and loss of efficacy over time.
Type 2 diabetes - A 2016 update by Zeena NackerdienZeena Nackerdien
The International Diabetes Federation maintains that one in two adults are undiagnosed for diabetes and that estimates that one in eleven people had diabetes in 2015. If one takes into account that most of the cases involves the preventable condition of Type 2 diabetes, it comes as no surprise that many countries are being hit by staggering socioeconomic costs. Diabetes sites, chat rooms, aps, and ads for ever-evolving and increasingly complex disease management schemes are commonplace on Google. But what does all the information mean? The American Diabetes Association, American Association of Clinical Endocrinologists, The Canadian Diabetes Association, WebMD, and the International Diabetes Federation resources served as the major resources for this accompanying slide deck that tries to unpack some of the major subtopics related to prediabetes and Type 2 diabetes. The slide deck is organized according to disease definition, epidemiology, etiology/pathophysiology, diagnosis, treatment, and prevention. Particular topics such as the early use of insulin could be expanded into several separate slide decks narrating benefits and risks with supporting evidence. However, this deck is meant to provide interested readers with an overview of the Type 2 diabetes literature landscape, with the caveat that specific cases and Type 2 diabetes-related complications should always be discussed with a healthcare provider.
Image credits: slideteam.net; Wikimedia
The worldwide explosion of obesity has resulted in an ever-increasing prevalence of type 2 diabetes. The importance of insulin resistance and β-cell dysfunction to the pathogenesis of type 2 diabetes was debated for a long time; many thought that insulin resistance was the main abnormality in type 2 diabetes, and that inability to secrete insulin was a late manifestation. This notion is now challenged. This presentation deals with the important contributing factors in the development of type 2 diabetes mellitus.
Shashikiran Umakanth made this presentation at the "First Endocrine Update Program” – ENDO EGYPT 2015, from 17-20 December 2015 in the Historic City of Luxor, Egypt. This endocrine update was organised by the Egyptian Association of Endocrinology , Diabetes and Atherosclerosis (EAEDA) in collaboration with the Endocrine Society, USA.
Type 2 dm gdm new updates & guidelinesSachin Verma
Type 2 diabetes is a multifactorial disorder characterised by progressive pancreatic beta-cell dysfunction and insulin- resistance, leading to relative insulin deficiency, chronic hyperglycaemia, and various complications.
The treatment options for this disorder, which aim at correcting one or other of the two major pathophysiological mechanisms, have been hamstrung by unacceptable side-effects, lack of patient acceptability, and loss of efficacy over time.
Type 2 diabetes - A 2016 update by Zeena NackerdienZeena Nackerdien
The International Diabetes Federation maintains that one in two adults are undiagnosed for diabetes and that estimates that one in eleven people had diabetes in 2015. If one takes into account that most of the cases involves the preventable condition of Type 2 diabetes, it comes as no surprise that many countries are being hit by staggering socioeconomic costs. Diabetes sites, chat rooms, aps, and ads for ever-evolving and increasingly complex disease management schemes are commonplace on Google. But what does all the information mean? The American Diabetes Association, American Association of Clinical Endocrinologists, The Canadian Diabetes Association, WebMD, and the International Diabetes Federation resources served as the major resources for this accompanying slide deck that tries to unpack some of the major subtopics related to prediabetes and Type 2 diabetes. The slide deck is organized according to disease definition, epidemiology, etiology/pathophysiology, diagnosis, treatment, and prevention. Particular topics such as the early use of insulin could be expanded into several separate slide decks narrating benefits and risks with supporting evidence. However, this deck is meant to provide interested readers with an overview of the Type 2 diabetes literature landscape, with the caveat that specific cases and Type 2 diabetes-related complications should always be discussed with a healthcare provider.
Image credits: slideteam.net; Wikimedia
Anti-diabetic Therapies, Strategies for Diabetes Management, and Advancement ...PriyankaKilaniya
Diabetes Mellitus (DM) stands as a prominent metabolic disorder characterized by impaired insulin activity and/or secretion, leading to various pathological complications such as nephropathy, retinopathy, and cardiovascular issues. This review delves into the intricacies of Diabetes Mellitus (DM), exploring its sub-types, conventional treatment modalities, and the emerging role of nanotechnology in revolutionizing drug delivery for improved therapeutic outcomes. Pathophysiology of Diabetes Mellitus manifests through aberrations in insulin dynamics, leading to hyperglycemia and subsequent tissue damage. Understanding the underlying pathophysiological mechanisms is crucial for devising effective therapeutic strategies. Classification of Diabetes Mellitus is broadly categorized into Type 1 and Type 2, each with distinct etiological factors and treatment approaches. Type 1 DM necessitates insulin replacement therapy, whereas Type 2 DM is primarily managed through oral hypoglycemic agents. Insulin replacement therapy is the cornerstone of treatment for Type 1 DM. It involves administering exogenous insulin to mimic the physiological insulin secretion that is deficient in individuals with T1DM. This aims to maintain blood glucose levels within a normal range to prevent acute as well as long-term complications. Drug therapy for Type 2 Diabetes Mellitus : The pharmacological armamentarium for Type 2 DM includes Insulin Secretagogues, Biguanides, Insulin Sensitizers, α-Glucosidase Inhibitors, Incretin Mimetics, Amylin Antagonists, and SGLT2 Inhibitors. The Complex pathophysiology of DM demands innovatives therapeutic approaches to enhance drug efficacy and patient adherence. Nanotechology offers promising solutions by enabling targeted drug delivery, improved bioavailability, and reduced dosing frequency. Clinical Implications and Future Perspectives Nanotechnology holds immense potential in revolutionizing diabetes management by addressing the limitations of conventional therapies and enhancing therapeutic efficacy. Future research endeavors should focus on translational studies to validate the clinical utility of nanotechnology-based drug delivery systems. In Conclusion, the integration of nanotechnology into Diabetes management offers a paradigm shift in therapeutic approaches, promising targeted drug delivery, improved bioavailability, and enhanced patient outcomes. Continued research and development in this field are imperative to realize the full potential of nanotechnology in combating the global burden of Diabetes Mellitus. In this article, we endeavor to delve into the pathophysiolgy of Diabetes Mellitus (DM), traditional treatment methods for both Type 1 (T1DM) and Type 2 (T2DM) diabetes, alongside innovative drug delivery strategies for managing Diabetes Mellitus.
COMPARATIVE ASSESSMENT OF THE EEFFECT OF ARGINASE INHIBITOR L-NORVALINE AND M...ShubhamBaliyan13
Having metabolic syndrome can induce the risk of developing especially Type 2 Diabetes, insulin resistance , Atherosclerosis, cardiovascular disease, visceral Obesity, Dyslipidemias.
This study aimed at determining the prevalence of metabolic syndrome ( MetS) and its individual components and the most critical predictive risk factors of MetS in Type 2 Diabetes .
Obesity context of type 2 diabetes and medication perspectivesApollo Hospitals
Drug therapy of obesity has harsh antecedent that many earlier introduced drugs are withdrawn from market. The drugs in present use lack sufficient long-term efficacy and safety data. The difficulty of reversing changing dietary habits and decline in physical activity, however, offers major scope for anti-obesity therapeutics, implied in managing the epidemic chronic inflammatory maladies and cardiovascular sequel. Metabolic syndrome, pre-diabetes and type 2 diabetes mellitus, commonly associate with obesity. Weight reduction is crucial to prevent and control type 2 diabetes. This emphasizes rational choice of therapeutic regimens that do not themselves cause weight gain, and better promote weight loss. Such an aspect is addressed briefly focusing upon the available newer anti-obesity drug options, in particular.
Slides Lezing Dr. Ir. Ben van Ommen TNO leefstijlcongresWim Tilburgs
Slides van de lezing van Dr. Ir. Ben van Ommen tijdens het eerste jaarlijkse leefstijlcongres georganiseerd door TNO en het Leids Universitair Medisch Centrum LUMC
Newer Anti-Hyperglycemic agents in type 2 Diabetes Mellitus e Expanding the h...Apollo Hospitals
Diabetes mellitus is a common, chronic and progressive disease resulting in micro and macrovascular complications. Many classes of drugs are available for treatment but still the search for newer anti-hyperglycemic agents continues to combat significant adverse effect profile, loss of efficacy, progressive nature of disease and improve patient compliance. New emerging therapies in pipeline include drugs targeting various pathophysiologic mechanisms like incretin based therapies, sodium glucose co-transporter inhibitors, glucokinase inhibitors, 11b hydroxy steroid dehydrogenase inhibitors, drugs modulating fatty acid metabolism, selective PPARg receptor modulators and anti inflammatory agents.
ABSTRACT
Over the last decade, diabetes mellitus has emerged as an important clinical and public health
problem throughout the world. The aim of the study is perceive the Potentiality of a newer oral
Antihyperglycemic combination therapy over conventional therapy in type 2 diabetes. The
prospective study was conducted over a period of six months in the department of Medicine,
Guntur City Hospital. The prevalence of type2 diabetes was high in male 65.79 % than female
34.21%. Majority of the patients (23.68 %) belonged to age group of 51–55 years. Majority of
patients (55.26%) having a family history of Diabetes. Majority of patients receiving Combination
of Glibenclamide + Metformin (60.53%), evaluated for effect on FPG for both combinations. The
mean changes in FPG were noted. In the same way effect on HbA1c also noted. Mean changes in
for every month HbA1c will be noted. Our study reveals that Combination therapy with Metformin
plus Glimepiride is more effective than Glibenclamide plus Metformin; in improving glycemic
control in type 2 diabetes, while also allowing a reduction of the dosage of each drug.
Continuous Care Intervention in Type 2 DiabetesJames McCarter
CME Talk at Washington University Kilo Diabetes Symposium, November 2nd, 2018. CME Objectives:
1. Describe the evidence for carbohydrate restriction in the management of type 2 diabetes.
2. Distinguish between nutritional ketosis, fasting ketosis and ketoacidosis.
3. Discuss the role of ketones as both energy sources and signaling molecules.
4. Discuss the rationale for reduction of glycemic-control prescriptions following implementation of nutritional ketosis in the treatment of type 2 diabetes.
5. Hypothesize factors that allow for sustained behavior change in diabetes reversal and remission.
Similar to Diabetes Mellitus - An Integrated Approach (20)
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. INTRODUCTION
• Diabetes mellitus is a metabolic disorder characterized by common feature of
hyperglycemia with disturbance of carbohydrate , fat and protein metabolism.
• Depending on the cause, it may be broadly classified into two main categories
• 1. TYPE 1
2. TYPE 2
3. GESTATIONAL
4. SECONDARY
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019– ADA,
7. PATHOPHYSIOLOGY
• INSULIN SECRETION:
Preproinsulin (86 aa)
proteolysis R. Endoplasmic reticulum
Proinsulin
further clevage
Insulin Golgi apparatus
(21aa) A chain B chain (30 aa)
C peptide
• C peptide – less succeptable to degradation in liver
• C peptide is used as a marker to distinguish the externally administered insulin and endogenously
secreted insulin
8.
9. • TYPE I DM:
1. Genetic Factor - HLA DR 3& 4
(Short arm of Ch 06 (HLA DR3 -5 fold risk & HLA DR4 7 fold risk)
(Human Leukocyte Antigen)
2. Auto Immunity
(Auto T cells and Bcells, islet cell antibodies – 90% 1 year before
Cytokines – beta cell destruction)
3. Environmental Factors
(race, ethnicity, hybrid foods, polluted water, soil)
16. • GIP - they slow the rate of absorption of
nutrients into the blood stream by reducing
gastric emptying and may directly reduce
food intake.
17. • INCRETINS
• Incretins are a group of metabolic hormones that stimulate a decrease in blood glucose levels by
stimulating the insulin secretion.
• Some incretins (GLP-1) also inhibit glucagon release from the alpha cells of the islets of Langerhans.
23. HYDROTHERAPY
TITLE AUTHOR CONCLUSION
Immediate hypoglycaemic effect
of two selective
Hydrotherapeutic procedures in
non insulin dependent Patients
of diabetes mellitus.
SUJATHA DINESH,
J Res Educ Indian Med,
2014
Neutral douche and Gastrohepatic pack can play a
important role in lowering the raised blood glucose
levels in patients with NIDDM.
Effect of cold hip baths on blood
glucose levels in patients with
type 2 diabetes mellitus: a pilot
study
A Mooventhan,
Diabetes and
Metabolism , 2019
• Doubling the metabolic rate
• TRPM8 (transient receptor potential melastatin
8) activation is associated with ‘browning’ of
white adipose tissue and acceleration of energy
utilization.
• CHBs are reported to promote parasympathetic
activation which, in turn, is known to promote
insulin secretion.
• exposure to cold (14–15℃) induces a 43%
increase in insulin sensitivity
24. TITLE AUTHOR CONCLUSION
The comparison of effects of
Contrast bath on circulation
of contralateral lower limb in
Type 2 Diabetic and healthy
women.
Zohreh,
Journal Of Rehabilitation
Science And Research, 2016
Contrast bath increases the digitalis pedis
pulse rate, local temperature by improving
the peripheral blood circulation in DM
patients and this effect is maintained for
longer duration when compared to control.
Whole body heat exposure
modulates acute glucose
metabolism.
Amy L Kimbal,
Int Jour Hyperthermia, 2018
Whole body heat exposure increases the
insulin sensitivity and brings sympathetic
and parasympathetic balance.
Effect of Steam Sauna Bath on
Fasting Blood Glucose Level in
Healthy Adults.
Vandana V, Prathap
Indian J Med Biochem, 2018
When given three times a week there is a
significant reduction in the fasting blood
glucose levels.
25. TITLE AUTHOR CONCLUSION
1. Emphasis of Naturopathy in
the Management of Type 2
Diabetes Mellitus
2. Effect of Two Months
Naturopathy Treatment in
Non Insulin Dependent
Diabetes Mellitus Patients.
3. Role of Naturopathy on
physical and Biochemical
Parameters in patients with
Type 2 DM
Rukamani Nair et al.,
JMSCR, 2016
Rukamani Nair et al.,
JMSCR, 2017
Rukmani Nair et al.,
Indian journal of
Traditional
Knowledge, 2019
COLD HIP BATH:
It excites the contraction of muscular
structures of viscera including, liver,
pancreas, bladder.. and thus helps to
improve their function.
MASSAGE:
The stress regulatory mechanism of
massage might be attributed to control of
stress hormone, permitting the body to use
insulin more effectively
MUD THERAPY:
The mud application to abdomen increases
the peripheral circulation, metabolic rate
and helps to reduce blood glucose levels.
26. MASSAGE
TITLE AUTHOR CONCLUSION
Tactile massage improves glycaemic
control in women with type 2 diabetes: a
pilot study
Andersson,
Pract Diab Int, 2004
There is a significant B-HbA1c reduction,
The possible mechanism might be the influence of tactile
massage on hypothalamo pituitary- adrenal axis, can
produce endocrine disturbances with consequent effects
on glucose metabolism.
How Effective is Swedish Massage on
Blood Glucose Level in Children with
Diabetes Mellitus?
Firoozeh Sajedi,
Acta Medica Iranica,
2011
Full body massage, exercise and diet modification to
children with diabetes mellitus , has lowered the anxiety
and stress hormones and improved clinical course
Effects of tactile massage on metabolic
biomarkers in patients with type 2
diabetes
Wändell,r
Diabetes and Metabolism
, 2013
There is a significant reduction in the BMI, FBS, HbA1C,
HOMA IR, with increase in serum insulin, and adinopectin
levels
Effects of Thai Foot Massage on Balance
Performance in Diabetic Patients with
Peripheral Neuropathy: A Randomized
Parallel-Controlled Trial
Uraiwan Chatchawan
Med Sci Monit Basic Res,
2015
The results of this study suggest that Thai foot massage is
a viable alternative treatment for balance performance,
ROM of the foot, and the foot sensation in diabetic patients
with peripheral neuropathy.
27. MAGNETOTHERAPY
TITLE AUTHOR CONCLUSION
The effect of electric field, magnetic
field, and infrared ray combination
to reduce HOMA-IR index and GLUT
4 in diabetic model of Mus
musculus.
Warani D, Husen S A
Lasers Medical Science ,
2019
Combined treatment of electric field, magnetic
field, and infrared ray have potential to reduce
insulin resistance due to improving blood
circulation and increasing intracellular Ca2+
level.
There is a significant reduction in fasting blood
glucose level and HOMA-IR index
(Insulin resistance can be quantified from high
number of HOMA-IR index and observed from
glucose transporter 4 (GLUT-4) translocation
on membrane of skeletal muscle cells.)
Transcranial Magnetotherapy in the
treatment of Psychosomatic
disorders in children with Type 1
Diabetes Mellitus
Yu.Filina
Neuroscience and
Behavioural Physiology ,
2010
With magnetotherapy treatment for 12 mins
there is a significant change in mood, behaviour,
activity of subcortical functions (memory,
emotion, hormonal balances, pleasure).
28. ACUPUNCTURE
TITLE AUTHOR CONCLUSION
Effect of Needling at CV-12
(Zhongwan) on Blood Glucose
Levels in Healthy Volunteers: A
Pilot Randomized Placebo
Controlled Trial
Sriloy Mohanty , A. Mooventhan
Journal of Acupuncture and
Meridian Studies, 2016
The results of this present study showed
that a 20- minute single session needling at
CV-12 acupuncture point without any
stimulation (manual or electrical)
produced a mild reduction in RBG levels in
healthy volunteers.
(CV 12 - it is considered a therapeutic point
for diseases of the digestive organs such as
the stomach, pancreas, and spleen)
Clinical study on acupuncture
and moxibustion for Diabetes
H Liao,
Chinese Acupuncture, 2007
Acupuncture, moxibustion or both when
given, the results are clinically significant
and better result is obtained when both
acupuncture and moxibustion is given.
29. YOGA
TITLE AUTHOR CONCLUSION
Effect of 12 weeks of yoga on
quality of life and Indian
Diabetes risk score in
Prediabetic and Diabetic Indian
Young Adults: RCT
Parvati Pal, G S Keerthi,
Journal of Clincal &
Diagnostic Research,
2017
12 week yoga therapy improved the QoL
among diabetics and attenuated the risk
among prediabetes individuals.
30. TITLE AUTHOR
Adherence to yoga and its resultant effects on blood glucose in Type 2
diabetes: A community-based follow-up study
Praveen Angadi, Aarti Jagannathan
International Journal Of Yoga, 2017
31. TITLE AUTHOR
Integrated Yoga and Naturopathy module in management of Metabolic
Syndrome: A case report
Swathi Gowda,
Journal of Ayurveda and Integrative Medicine, 2017
32.
33. DIET
TITLE AUTHOR CONCLUSION
Effectiveness of Antihyperglycemic
Effect of Momordica charantia:
Implication of T-Cell Cytokines
Rufine Fachinan,
Evidence-Based
Complementary and
Alternative Medicine
TH2-immunosuppressive action of M. charantia
fruit juice could be beneficial to prevent infiltration
and destruction of 𝛽-cells by T-lymphocytes in
pancreas and therefore prevent hyperglycemia.
Bitter melon (Momordica charantia):
A review of efficacy and safety
Ethan Basch,
American Journal Of
Health System And
Pharmacology, 2003
Decrease hepatic gluconeogenesis,
increase hepatic glycogen synthesis,
increase peripheral glucose oxidation in
adipocytes.
Effects of meal replacement therapy
on metabolic outcomes in Thai
patients with type 2 diabetes: A
randomized controlled trial
Apussanee
Boonyavarakul,
Nutrition and Health,
2018
Short-term conventional low-Glycemic Index diet
control showed decreased BW, BMI, HbA1c, total
cholesterol and triglycerides and also great
decrease in LDL levels
Do Cinnamon Supplements Have a
Role in Glycemic Control in Type 2
Diabetes – A Narrative Review?
Rebecca B. Costello,
J Acad Nutr Diet, 2007
Among 11 RCTs reviewed, 10 showed significant
change in FBS and HBA1C, and the doses varies
from 1.2 to 6gm/d.
34.
35. • Targeting AMPK signaling pathway
by natural products for treatment
of diabetes mellitus and its
complications, Tanuj Joshi, Cellular
Physiology , 2018
36. • Polyphenols and Glycemic Control , Yoona Kim, Jennifer B. Keogh and Peter M. Clifton, Nutrients, 2016
37. • Circulating levels of antioxidant Indoleproprionic acid are associated with higher gut
microbiome diversity, Menni C , 2019
• Gut microbiota – tryptophan metabolism – end product (IPA) – important regulator for
insulin resistance.
• Faecalibacterium and Coprococcus – Abdominal Obesity
• Lachnospiraceae – visceral fat deposition
• 6% change in flora – 1% change in metabolism
Polyphenols group of phytochemicals containing phenol rings – (broccoli, onion ,cabbage, grapes, pears, apples, cherries, soya beans and various berries)